New diabetes drug approved; Study: Charity care threshold may be tricky proposition;

> The FDA has approved a diabetes drug, Saxagliptin, that will compete with Merck's Januvia. It's the second on the market in a new class known as DPP-4 inhibitors. Article

> Should the feds impose a minimum level of charity care non-profit hospitals must meet to merit their tax-exemption? One study, looking at the state of Maryland's experience, suggests that it would be a bad idea. FierceHealthFinance

> When it comes to rolling out electronic medical records, there's no such thing as too much good advice. Why not try these tips for EMR integration on for size? FierceEMR

And Finally... I have no idea how you'd haul this stuff away. Wouldn't you lose most of it in the process? Article